What do we measure when observing Inserm from the perspective of its missions, scope, and impact on French biomedical research? The National Institute of Health and Medical Research, established in 1964, is the only French public organization entirely dedicated to biological, medical, and human health research.
Under the dual supervision of the Ministry of Health and the Ministry of Research, it brings together researchers, engineers, technicians, and administrative staff around a common goal: to advance knowledge about living organisms and diseases to improve everyone’s health.
Further reading : The Private Life of Alicia Dauby and Olivier Bossard: A Discreet Marriage in the Spotlight
Strategic programming of health research: what has changed since 2024
The least visible aspect of Inserm concerns its role as a driver of national programming in biology-health. Since 2024, the institute has coordinated a Health Research Program Agency, responsible for planning scientific priorities on issues such as emerging infectious diseases, climate change-related pathologies, or chronic inflammatory diseases.
This mechanism goes beyond the simple production of laboratory results. It aims to anticipate future health crises by structuring research axes upstream, for example, on neurodegenerative diseases or hantaviruses. This mission of national strategic programming distinguishes Inserm from a traditional research organization and brings it closer to an agency-like function.
You may also like : How to check the blacklist of real estate developers in France in 2026?
To better understand the institutional scope and coordinates of the organization, a detailed sheet explains what Inserm is on (wo)menweb by intersecting official missions and practical data.
Organization of Inserm: supervision, thematic institutes, and international cooperation
The architecture of the institute is based on several interwoven levels. The dual ministerial supervision sets political directions. Nine thematic institutes assess the state of research in their field and animate the corresponding scientific community.
| Dimension | Inserm Scope | Particularity |
|---|---|---|
| Legal Status | Public establishment of a scientific and technological nature (EPST) | Only 100% French EPST dedicated to human health |
| Supervision | Ministry of Health and Ministry of Research | Dual supervision, rare among research organizations |
| Thematic Institutes | Nine institutes covering fundamental biology to public health | Animation and mapping of each disciplinary field |
| International Cooperation | Presence in over 100 countries | More than half of collaborations in Europe, a quarter in the United States |
| Valorization | Inserm Transfert (private subsidiary) | Transfer of results to industry and society |
International cooperation relies on several tools: International Launchpads, International Research Projects (PRI), Key International Partnerships (PIC), Joint Labs, and Thematic Coordination Programs (PCT). More than 7,000 cooperation agreements structure these exchanges worldwide.
Biomedical research and concrete advancements: the scientific assessment of Inserm
Inserm positions itself across the entire journey from the laboratory to the patient’s bedside. Since 1964, the institute has contributed to advancements that have changed medical practice:
- First prenatal diagnostic tests and decoding the mechanisms of the HLA system, proteins that allow the immune system to distinguish the body’s cells from foreign cells
- First in vitro fertilization in France and identification of the AIDS virus, two milestones that have redefined reproductive medicine and infectious disease
- Development of deep brain stimulation, a technique involving the implantation of electrodes in specific brain structures to deliver a low-intensity electric current
- Advancements in gene therapy and radiotherapy against cancer, with direct impacts on treatment protocols
This assessment illustrates a constant: Inserm produces fundamental research that translates into clinical applications. The Inserm Transfert subsidiary, created to economically valorize these results, carries three missions of valorization and innovation defined by decree: protecting and developing innovations, structuring industrial partnerships, and supporting the creation of startups arising from laboratories.
Ethics, patient relations, and dissemination of scientific knowledge
Ethics is a structuring axis of Inserm’s activity, not just a simple display of values. The institute is involved in scientific evaluation, defining ethical frameworks for research involving human subjects, and reflecting on the uses of health data.
The relationship with patient associations and the sick forms another pillar. Inserm involves patients in defining research priorities, which goes beyond the usual framework of recruitment for clinical trials. This participatory approach also fuels the dissemination of knowledge: podcasts, journals like médecine/sciences, and publications accessible to the general public.
In terms of human resources, the institute structures the careers of its scientific and technical staff through social action, training, and support initiatives. The management of these professional paths reflects an organization that goes beyond mere academic production to integrate working conditions as a lever for scientific quality.
Inserm thus operates on three simultaneous axes: fundamental and clinical research, national strategic programming, and societal engagement. The data that best summarizes its positioning remains its institutional uniqueness: no other French public organization concentrates all its resources on research in human health, from fundamental biology to public health, with a coordination capacity that now extends to planning research priorities in response to health and climate crises.